Magnesium Blood Pressure Randomized Trial Evidence Table

Structured evidence table for Magnesium Blood Pressure Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Magnesium Blood Pressure Randomized TrialDespite major advancements in pharmacotherapies and interventional cardiology, substantial residual risk persists among patients with established disease ().3Wu Xun (2026)Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives
Magnesium Blood Pressure Randomized TrialAdditionally, many nutraceuticals are perceived to possess favorable safety and tolerability profiles compared to conventional medications, making them attractive for long-term risk reduction ().3Wu Xun (2026)Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives
Magnesium Blood Pressure Randomized TrialBanach et al., 2018 Cicero et al., 2017 Sesso et al., 2008 However, the field is marked by heterogeneous and sometimes contradictory evidence.3Wu Xun (2026)Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives
Magnesium Blood Pressure Randomized TrialRoth et al., 2020 Ganda et al., 2018 Visseren et al., 2021 Cardiovascular disease (CVD) is the leading cause of mortality worldwide, accounting for nearly one-third of global deaths each year ().3Wu Xun (2026)Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives
Magnesium Blood Pressure Randomized TrialThis mechanism ensured that both the surgical team and the investigators performing postoperative assessments remained blinded to the treatment allocation until the conclusion of the study.4Farahani Parham Khoshdani (2026)Local dexamethasone and magnesium sulfate for postoperative pain management in septorhinoplasty: A clinical evaluation
Magnesium Blood Pressure Randomized TrialTo handle the large volume of hemodynamic data generated by high-frequency monitoring (every 30 s), raw blood pressure and heart rate measurements were reduced to Time-Weighted Averages (TWA).4Farahani Parham Khoshdani (2026)Local dexamethasone and magnesium sulfate for postoperative pain management in septorhinoplasty: A clinical evaluation
Magnesium Blood Pressure Randomized TrialThe mean age in the study group was 26.3 ± 7.2 years, and in the control group 25.7 ± 3.5 years; no significant difference was found between the groups based on the independent-test (= 0.21).4Farahani Parham Khoshdani (2026)Local dexamethasone and magnesium sulfate for postoperative pain management in septorhinoplasty: A clinical evaluation
Magnesium Blood Pressure Randomized TrialDespite significant advances in pain management, postoperative pain remains a major clinical problem, and progress in this area has been unacceptably slow.4Farahani Parham Khoshdani (2026)Local dexamethasone and magnesium sulfate for postoperative pain management in septorhinoplasty: A clinical evaluation

Source documents

  1. Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives
  2. Local dexamethasone and magnesium sulfate for postoperative pain management in septorhinoplasty: A clinical evaluation